According to the Boston Business Journal, “Two co-located Watertown companies that got a new CEO earlier this year have together raised $26.5 million in debt and equity financing to fund development of treatments to help the body heal after vascular disease and during abdominal hemorrhaging.”  For more information on this acquisition, please visit: